ProterixBio

About:

ProterixBio engages in developing innovative products to transform the management of chronic diseases.

Website: https://proterixbio.com/

Top Investors: New York Angels, Morningside Group, New Science Ventures, Blackfin Technology, F2 Ventures

Description:

Developer of proprietary blood-based biomarker tests to transform the management of chronic respiratory diseases. The company is focused on addressing the unmet need for tools to provide a real-time, biological assessment of a patient’s disease state. ProterixBio's products will enable health care providers to better manage their patients and avoid unnecessary hospitalizations, leading to improved outcomes and reduced health care costs. It was founded in 2002 and headquartered in Billerica, Massachusetts.